VCAN (Versican core protein) variants and mutations
VCAN (also known as Versican core protein) is a human protein-coding gene encoding a versican core protein. It provides a large hydrated extracellular-matrix scaffold that regulates cell adhesion, migration, tissue mechanics, and development. Pathogenic variants can cause Wagner vitreoretinopathy, while altered expression and processing are important in cardiovascular remodeling, inflammation, and cancer. This analysis covers 4,677 VCAN variants and mutations. Of these, 68% have computational variant effect predictions. Disease context includes Wagner disease, Abnormality of the skeletal system, and diverticular disease. Example VCAN variants include F2L, F2F, and N4D.
Variant analysis overview
- Gene: VCAN
- Protein: Versican core protein
- UniProt accession: P13611
- Organism: Homo sapiens
- Variants analyzed: 4677
- Variant scope: all variants
- Completed: 2026-08-22
Variant and mutation evidence
- Variant composition: 4,368 unspecified-consequence records; 152 missense variants; 146 synonymous variants; 3 stop-gained variants; 3 in-frame deletions; 1 in-frame insertions; 3 frameshift variants; 1 splice-region variants; 1 substitution
- Prediction scores: 3,184 variants have prediction scores (68% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: Wagner disease, Abnormality of the skeletal system, diverticular disease, Retinal dystrophy, hereditary disease, eye disorder, abdominal aortic aneurysm, aortic aneurysm, carpal tunnel syndrome, Stickler syndrome, post term pregnancy, myopia 25, autosomal dominant.
Protein structure and variant hotspots
- Protein features: 7 domains; 37 post-translational modification sites.
- Structural context: 909 variants have structural context.
- PTM context: 47 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, AlphaFold DB, gnomAD constraint, Open Targets, MaveDB, LitVar.
Notable VCAN variants
Examples include F2L, F2F, N4D, I5M, I5T, I5V, I5L, K6E. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- F2L (p.Phe2Leu), gnomAD 5-83483522-T-C, REVEL 0.08, CADD 13.20
- F2F (p.Phe2Phe), rs966795182, gnomAD 5-83483524-C-T, CADD 11.70
- N4D (p.Asn4Asp), gnomAD rs1744684342, REVEL 0.07, CADD 23.60
- I5M (p.Ile5Met), ExAC rs754050405, gnomAD rs754050405, REVEL 0.06, CADD 18.10
- I5T (p.Ile5Thr), rs766706928, ClinGen CA3332353, ClinVar RCV002011538, ExAC rs766706928, REVEL 0.44, CADD 24.30, Uncertain significance, not provided
- I5V (p.Ile5Val), gnomAD 5-83483531-A-G, REVEL 0.05, CADD 20.70
- I5L (p.Ile5Leu), gnomAD 5-83483531-A-C, REVEL 0.08, CADD 23.30
- K6E (p.Lys6Glu), ExAC rs759551552, gnomAD rs759551552
- K6M (p.Lys6Met), TOPMed rs1440057378, gnomAD rs1440057378, REVEL 0.44, CADD 26.60, Uncertain significance, not provided
- K6N (p.Lys6Asn), Ensembl rs868477733, REVEL 0.08, CADD 18.00, Uncertain significance, not provided
- K6R (p.Lys6Arg), NCI-TCGA Cosmic COSV5409, cosmic curated COSV54098, NCI-TCGA Cosmic COSV5410, Variant assessed as somatic; moderate impact.
- K6K (p.Lys6Lys), gnomAD 5-83483536-G-A, CADD 7.37
- S7I (p.Ser7Ile), NCI-TCGA Cosmic COSV5410, cosmic curated COSV54102, Variant assessed as somatic; moderate impact.
- S7N (p.Ser7Asn), NCI-TCGA Cosmic COSV5410, gnomAD rs1744685152, REVEL 0.04, CADD 22.80, Variant assessed as somatic; moderate impact.
- S7R (p.Ser7Arg), gnomAD rs1173061956, NCI-TCGA Cosmic COSV5410, cosmic curated COSV54105, REVEL 0.20, CADD 24.00, Variant assessed as somatic; moderate impact.
- S7T (p.Ser7Thr), gnomAD 5-83483538-G-C, REVEL 0.06, CADD 23.00
- I8V (p.Ile8Val), gnomAD rs1364115245, REVEL 0.04, CADD 18.00
- M11I (p.Met11Ile), ExAC rs765316352, gnomAD rs765316352, REVEL 0.03, CADD 16.50
- M11L (p.Met11Leu), rs2478944975, ClinGen CA360293162, ClinVar RCV003543809, Uncertain significance, not provided
- C12* (p.Cys12Ter), NCI-TCGA Cosmic COSV5410, cosmic curated COSV54106, Variant assessed as somatic; high impact.
- C12C (p.Cys12Cys), rs113090098, gnomAD 5-83483554-T-C, CADD 7.71
- S13T (p.Ser13Thr), gnomAD 5-83483555-T-A, REVEL 0.16, CADD 23.50
- S13S (p.Ser13Ser), gnomAD 5-83483557-A-C, CADD 7.83
- T14I (p.Thr14Ile), gnomAD rs1304018175, REVEL 0.06, CADD 21.50
- T14S (p.Thr14Ser), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L15V (p.Leu15Val), gnomAD 5-83483561-T-G, REVEL 0.13, CADD 23.70
- L15* (p.Leu15Ter), gnomAD 5-83483562-T-G, CADD 36.00
- I16L (p.Ile16Leu), 1000Genomes rs573332559, REVEL 0.03, CADD 14.90, Uncertain significance
- I16T (p.Ile16Thr), gnomAD rs1367479916, REVEL 0.10, CADD 22.90
- I16V (p.Ile16Val), rs573332559, ClinGen CA360293196, ClinVar RCV001763340, 1000Genomes rs573332559, REVEL 0.03, CADD 10.70, Uncertain significance, not provided
- I16M (p.Ile16Met), gnomAD 5-83483566-A-G, REVEL 0.12, CADD 23.10
- V17E (p.Val17Glu), TOPMed rs1312762271
- V17L (p.Val17Leu), TOPMed rs1321058056
- V17I (p.Val17Ile), gnomAD 5-83483567-G-A, REVEL 0.06, CADD 14.10
- V17A (p.Val17Ala), gnomAD 5-83483568-T-C, REVEL 0.04, CADD 9.48
- T18A (p.Thr18Ala), ExAC rs751482841, gnomAD rs751482841, REVEL 0.07, CADD 15.70
- T18S (p.Thr18Ser), gnomAD 5-83483570-A-T, REVEL 0.09, CADD 18.70
- T18T (p.Thr18Thr), rs757188535, gnomAD 5-83483572-C-A, CADD 5.83
- H19P (p.His19Pro), ExAC rs781014698, TOPMed rs781014698, gnomAD rs781014698, REVEL 0.31, CADD 22.80, Uncertain significance, Inborn genetic diseases
- H19Q (p.His19Gln), rs1561225260, Ensembl rs1561225260, ClinGen CA360293218, ClinVar RCV003059536, REVEL 0.07, CADD 16.10, Uncertain significance, not provided
- H19R (p.His19Arg), ExAC rs781014698, TOPMed rs781014698, gnomAD rs781014698, REVEL 0.17, CADD 18.50
- H19Y (p.His19Tyr), rs2478945092, ClinGen CA360293214, ClinVar RCV003720983, Uncertain significance, not provided
- A20E (p.Ala20Glu), rs750206974, NCI-TCGA Cosmic COSV5411, cosmic curated COSV54114, ExAC rs750206974, REVEL 0.27, CADD 23.10, Variant assessed as somatic; moderate impact.
- A20S (p.Ala20Ser), TOPMed rs1216091543, gnomAD rs1216091543, REVEL 0.15, CADD 22.60
- A20T (p.Ala20Thr), TOPMed rs1216091543, gnomAD rs1216091543
- A20V (p.Ala20Val), ExAC rs750206974, TOPMed rs750206974, gnomAD rs750206974, REVEL 0.11, CADD 22.00
- A20A (p.Ala20Ala), rs755828566, gnomAD 5-83483578-G-T, CADD 0.41
- L21P (p.Leu21Pro), NCI-TCGA Cosmic COSV5410, cosmic curated COSV54103, Variant assessed as somatic; moderate impact.
- H22Y (p.His22Tyr), rs748911990, ClinGen CA3332363, ClinVar RCV003055019, ExAC rs748911990, REVEL 0.13, CADD 18.40, Uncertain significance, not provided
- H22R (p.His22Arg), gnomAD 5-83483583-A-G, REVEL 0.04, CADD 3.15
- K23* (p.Lys23Ter), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99424, Variant assessed as somatic; high impact.
- K23N (p.Lys23Asn), rs768072971, ClinGen CA3332364, ClinVar RCV003035359, ClinVar RCV005930278, REVEL 0.14, CADD 23.30, Uncertain significance, not provided
- V24L (p.Val24Leu), TOPMed rs1744688921
- V24I (p.Val24Ile), gnomAD 5-83483588-G-A, REVEL 0.18, CADD 26.30
- K25Q (p.Lys25Gln), gnomAD 5-83490100-A-C, REVEL 0.11, CADD 16.10
- K25R (p.Lys25Arg), gnomAD 5-83490101-A-G, REVEL 0.13, CADD 23.90
- K25K (p.Lys25Lys), rs2112352958, gnomAD 5-83490102-A-G, CADD 5.00
- V26A (p.Val26Ala), rs2112352970, ClinGen CA360294736, ClinVar RCV002010653, Ensembl rs2112352970, REVEL 0.10, CADD 15.20, Uncertain significance, not provided
- V26M (p.Val26Met), ESP rs150373747, gnomAD rs150373747, REVEL 0.13, CADD 9.30
- G27R (p.Gly27Arg), gnomAD 5-83490106-G-A, REVEL 0.13, CADD 22.50
- G27V (p.Gly27Val), gnomAD 5-83490107-G-T, REVEL 0.09, CADD 15.40
- K28E (p.Lys28Glu), gnomAD 5-83490109-A-G, REVEL 0.12, CADD 17.30
- S29G (p.Ser29Gly), TOPMed rs1239414604, gnomAD rs1239414604, REVEL 0.07, CADD 12.50
- S29I (p.Ser29Ile), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S29R (p.Ser29Arg), gnomAD rs1256229710, REVEL 0.07, CADD 6.47
- S29N (p.Ser29Asn), gnomAD 5-83490113-G-A, REVEL 0.04, CADD 6.57
- S29S (p.Ser29Ser), rs1256229710, gnomAD 5-83490114-C-T, CADD 1.77
- P30L (p.Pro30Leu), TOPMed rs202176395, gnomAD rs202176395, REVEL 0.17, CADD 16.80
- P30Q (p.Pro30Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- P30S (p.Pro30Ser), rs138176813, ClinGen CA3332386, ClinVar RCV002622119, ESP rs138176813, REVEL 0.08, CADD 15.80, Uncertain significance, not provided
- P31L (p.Pro31Leu), rs776898982, ClinGen CA3332387, NCI-TCGA Cosmic COSV5409, cosmic curated COSV54099, REVEL 0.20, CADD 16.50, Uncertain significance, Inborn genetic diseases; not provided
- P31Q (p.Pro31Gln), NCI-TCGA Cosmic COSV5409, Variant assessed as somatic; moderate impact.
- P31S (p.Pro31Ser), gnomAD 5-83490118-C-T, REVEL 0.03, CADD 1.25
- P31P (p.Pro31Pro), rs771456960, gnomAD 5-83490120-G-A, CADD 2.02
- V32M (p.Val32Met), gnomAD 5-83490121-G-A, REVEL 0.45, CADD 22.00
- V32L (p.Val32Leu), gnomAD 5-83490121-G-T, REVEL 0.25, CADD 16.60
- R33G (p.Arg33Gly), TOPMed rs1392476275
- R33W (p.Arg33Trp), NCI-TCGA Cosmic COSV5409, cosmic curated COSV54097, Variant assessed as somatic; moderate impact.
- R33K (p.Arg33Lys), gnomAD 5-83490125-G-A, REVEL 0.06, CADD 4.80
- G34D (p.Gly34Asp), TOPMed rs1189580528, REVEL 0.58, CADD 24.50, Uncertain significance, not provided
- G34S (p.Gly34Ser), Ensembl rs1744928978, REVEL 0.39, CADD 25.60
- G34V (p.Gly34Val), TOPMed rs1189580528
- G34G (p.Gly34Gly), gnomAD 5-83490129-C-G, CADD 6.71
- S35T (p.Ser35Thr), gnomAD 5-83490130-T-A, REVEL 0.23, CADD 23.40
- S35C (p.Ser35Cys), gnomAD 5-83490131-C-G, REVEL 0.45, CADD 22.70
- S35S (p.Ser35Ser), gnomAD 5-83490132-C-T, CADD 7.26
- L36I (p.Leu36Ile), cosmic curated COSV99426, ExAC rs777022702, TOPMed rs777022702, gnomAD rs777022702, REVEL 0.28, CADD 23.70
- L36V (p.Leu36Val), ExAC rs777022702, TOPMed rs777022702, gnomAD rs777022702, REVEL 0.30, CADD 23.60
- L36L (p.Leu36Leu), gnomAD 5-83490135-C-A, CADD 5.97
- S37A (p.Ser37Ala), rs142740596, ClinGen CA3332390, ClinVar RCV000344353, ClinVar RCV002061295, REVEL 0.10, CADD 23.10, Conflicting interpretations, not provided; Vitreoretinopathy; Inborn genetic diseases
- S37F (p.Ser37Phe), ExAC rs770045298, gnomAD rs770045298, REVEL 0.42, CADD 26.10, Uncertain significance, Retinal dystrophy
- S37Y (p.Ser37Tyr), ExAC rs770045298, gnomAD rs770045298, REVEL 0.44, CADD 25.30, Uncertain significance
- S37S (p.Ser37Ser), rs1744929976, gnomAD 5-83490138-T-G, CADD 7.98
- K39K (p.Lys39Lys), rs775501378, gnomAD 5-83490144-A-G, CADD 11.30
- V40F (p.Val40Phe), rs763096343, ClinGen CA3332394, ClinVar RCV001980364, ExAC rs763096343, REVEL 0.60, CADD 25.10, Uncertain significance, not provided
- V40G (p.Val40Gly), ESP rs376593002, ExAC rs376593002, TOPMed rs376593002, gnomAD rs376593002, REVEL 0.73, CADD 24.60
- V40I (p.Val40Ile), rs763096343, ClinGen CA3332393, ClinVar RCV002617234, ExAC rs763096343, REVEL 0.24, CADD 24.40, Uncertain significance, not provided
- V40L (p.Val40Leu), cosmic curated COSV54103, ExAC rs763096343, TOPMed rs763096343, gnomAD rs763096343, REVEL 0.28, CADD 23.30, Uncertain significance
- V40V (p.Val40Val), rs1744930574, gnomAD 5-83490147-C-G, CADD 9.12
- L42Q (p.Leu42Gln), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- L42L (p.Leu42Leu), rs1279795890, gnomAD 5-83490151-C-T, CADD 9.27
- P43L (p.Pro43Leu), ESP rs146100935, ExAC rs146100935, TOPMed rs146100935, gnomAD rs146100935, REVEL 0.64, CADD 26.60
- P43S (p.Pro43Ser), rs1221199398, ClinGen CA360294918, ClinVar RCV002836006, ClinVar RCV005059303, REVEL 0.61, CADD 25.40, Uncertain significance, Inborn genetic diseases; not provided
- H45P (p.His45Pro), Ensembl rs1744931332
- H45Q (p.His45Gln), rs369760896, ClinGen CA3332399, ClinVar RCV001968697, ESP rs369760896, REVEL 0.11, CADD 23.30, Uncertain significance, not provided
- H45Y (p.His45Tyr), rs371177155, ClinGen CA3332398, ClinVar RCV001370423, ClinVar RCV003169905, REVEL 0.11, CADD 23.00, Uncertain significance, Inborn genetic diseases; not provided
- H45R (p.His45Arg), gnomAD 5-83490161-A-G, REVEL 0.12, CADD 22.70
- F46S (p.Phe46Ser), gnomAD rs1744931574, REVEL 0.79, CADD 29.90
- S47S (p.Ser47Ser), rs764950063, gnomAD 5-83490168-A-G, CADD 7.16
- T48A (p.Thr48Ala), cosmic curated COSV99426, ExAC rs752236125, gnomAD rs752236125, REVEL 0.22, CADD 25.30
- T48M (p.Thr48Met), rs201043051, ClinGen CA3332402, cosmic curated COSV54104, ClinVar RCV001369660, REVEL 0.24, CADD 23.00, Uncertain significance, Inborn genetic diseases; not provided
- T48N (p.Thr48Asn), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- T48T (p.Thr48Thr), rs777382241, gnomAD 5-83490171-G-A, CADD 1.52
- M49K (p.Met49Lys), ExAC rs747560101, gnomAD rs747560101
- M49T (p.Met49Thr), ExAC rs747560101, gnomAD rs747560101
- P50L (p.Pro50Leu), rs1197442253, ClinGen CA360295004, ClinVar RCV002654428, TOPMed rs1197442253, REVEL 0.39, CADD 24.60, Uncertain significance, not provided
- P50S (p.Pro50Ser), gnomAD 5-83490175-C-T, REVEL 0.19, CADD 23.70
- P50P (p.Pro50Pro), rs757817621, gnomAD 5-83490177-T-G, CADD 3.75
- T51S (p.Thr51Ser), gnomAD 5-83490178-A-T, REVEL 0.11, CADD 23.20
- L52L (p.Leu52Leu), rs1470196352, gnomAD 5-83490181-T-C, CADD 7.33
- L52S (p.Leu52Ser), gnomAD 5-83490182-T-C, REVEL 0.06, CADD 24.40
- L52F (p.Leu52Phe), gnomAD 5-83490183-G-C, REVEL 0.13, CADD 22.40
- P53S (p.Pro53Ser), rs201466502, ClinGen CA3332406, ClinVar RCV001046583, ClinVar RCV001154162, REVEL 0.08, CADD 16.50, Conflicting interpretations, Inborn genetic diseases; not provided; Vitreoretinopathy
- P53P (p.Pro53Pro), rs1744932735, gnomAD 5-83490186-A-C, CADD 11.60
- P54S (p.Pro54Ser), rs140063016, ClinGen CA3332407, ClinVar RCV001067230, ClinVar RCV001154164, REVEL 0.14, CADD 22.70, Conflicting interpretations, not provided; Wagner disease; Vitreoretinopathy
- P54H (p.Pro54His), gnomAD 5-83490188-C-A, REVEL 0.21, CADD 24.60
- P54P (p.Pro54Pro), gnomAD 5-83490189-C-G, CADD 6.39
- S55G (p.Ser55Gly), gnomAD 5-83490190-A-G, REVEL 0.12, CADD 12.50
- S55I (p.Ser55Ile), gnomAD 5-83490191-G-T, REVEL 0.14, CADD 22.50
- N57H (p.Asn57His), TOPMed rs1744933219
- N57T (p.Asn57Thr), rs2478963803, ClinGen CA360295087, ClinVar RCV003716272, REVEL 0.03, CADD 21.50, Uncertain significance, not provided
- N57del (p.Asn57del), gnomAD 5-83490193-TACA-T, CADD 14.90
- N57S (p.Asn57Ser), gnomAD 5-83490197-A-G, REVEL 0.03, CADD 19.90
- N57N (p.Asn57Asn), rs1744933361, gnomAD 5-83490198-C-T, CADD 6.78
- T58I (p.Thr58Ile), gnomAD 5-83490200-C-T, REVEL 0.09, CADD 22.90
- S59G (p.Ser59Gly), TOPMed rs1367769624
- S59I (p.Ser59Ile), rs769983691, ClinGen CA3332408, ClinVar RCV003546220, ExAC rs769983691, REVEL 0.26, CADD 23.40, Uncertain significance, not provided
- S59R (p.Ser59Arg), ExAC rs775793051, gnomAD rs775793051, REVEL 0.13, CADD 13.60
- E60A (p.Glu60Ala), rs2478963868, ClinGen CA360295130, ClinVar RCV003205307, Uncertain significance, Inborn genetic diseases
- E60V (p.Glu60Val), rs2478963868, ClinGen CA360295127, ClinVar RCV002735388, Uncertain significance, not provided
- F61L (p.Phe61Leu), rs2478963896, ClinGen CA360295146, ClinVar RCV002948573, REVEL 0.09, CADD 24.00, Uncertain significance, not provided
- F61C (p.Phe61Cys), gnomAD 5-83490209-T-G, REVEL 0.40, CADD 24.90
- F61F (p.Phe61Phe), gnomAD 5-83490210-T-C, CADD 11.70
- L62V (p.Leu62Val), gnomAD 5-83490211-C-G, REVEL 0.23, CADD 24.40
- L62L (p.Leu62Leu), rs765528482, gnomAD 5-83490213-C-A, CADD 8.65
- R63C (p.Arg63Cys), rs977327386, ClinGen CA121775320, NCI-TCGA Cosmic COSV5410, cosmic curated COSV54103, REVEL 0.62, CADD 25.80, Uncertain significance, not provided; Inborn genetic diseases
- R63H (p.Arg63His), rs142148754, ClinGen CA3332410, cosmic curated COSV54104, ClinVar RCV001979666, REVEL 0.58, CADD 31.00, Uncertain significance, not provided
- R63L (p.Arg63Leu), rs142148754, ClinGen CA360295161, ClinVar RCV001238304, NCI-TCGA TCGA novel, REVEL 0.62, CADD 30.00, Uncertain significance, not provided
- K65K (p.Lys65Lys), rs768754493, gnomAD 5-83490222-A-G, CADD 9.88
- W66* (p.Trp66Ter), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99427, Variant assessed as somatic; high impact.
- S67C (p.Ser67Cys), cosmic curated COSV99426, gnomAD rs1224614164, REVEL 0.44, CADD 25.30, Uncertain significance, not provided
- S67A (p.Ser67Ala), gnomAD 5-83490226-T-G, REVEL 0.36, CADD 26.40
- S67F (p.Ser67Phe), gnomAD 5-83490227-C-T, REVEL 0.39, CADD 25.60
- S67S (p.Ser67Ser), gnomAD 5-83490228-T-A, CADD 9.90
- K68* (p.Lys68Ter), NCI-TCGA TCGA novel, Variant assessed as somatic; high impact.
- K68E (p.Lys68Glu), ExAC rs774378378, TOPMed rs774378378, gnomAD rs774378378, REVEL 0.66, CADD 27.80
- I69T (p.Ile69Thr), rs1465864734, ClinGen CA360295239, ClinVar RCV002701186, TOPMed rs1465864734, REVEL 0.47, CADD 27.00, Uncertain significance, Inborn genetic diseases; not provided
- E70* (p.Glu70Ter), NCI-TCGA Cosmic COSV5409, cosmic curated COSV54099, Variant assessed as somatic; high impact.
- E70G (p.Glu70Gly), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99425, Variant assessed as somatic; moderate impact.
- E70V (p.Glu70Val), ExAC rs760651552, gnomAD rs760651552
- V71A (p.Val71Ala), TOPMed rs753208147, gnomAD rs753208147, REVEL 0.03, CADD 20.80, Uncertain significance, Inborn genetic diseases
- D72G (p.Asp72Gly), rs963729586, ClinGen CA121775330, ClinVar RCV001349960, TOPMed rs963729586, REVEL 0.11, CADD 27.80, Uncertain significance, not provided
- D72N (p.Asp72Asn), rs766324236, ClinGen CA3332414, NCI-TCGA Cosmic COSV5411, cosmic curated COSV54115, REVEL 0.20, CADD 27.00, Uncertain significance, not provided
- K73R (p.Lys73Arg), Ensembl rs954543050
- K73E (p.Lys73Glu), gnomAD 5-83490244-A-G, REVEL 0.23, CADD 25.70
- N74I (p.Asn74Ile), ESP rs144766017, ExAC rs144766017, TOPMed rs144766017, gnomAD rs144766017, Benign
- N74S (p.Asn74Ser), rs144766017, ClinGen CA3332415, ClinVar RCV001051916, ClinVar RCV001154166, REVEL 0.08, CADD 0.11, Conflicting interpretations, not provided; Vitreoretinopathy; Wagner disease
- G75R (p.Gly75Arg), NCI-TCGA Cosmic COSV9942, cosmic curated COSV99424, Variant assessed as somatic; moderate impact.
- G75V (p.Gly75Val), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D77N (p.Asp77Asn), rs2112353375, ClinGen CA360295348, ClinVar RCV001942822, Ensembl rs2112353375, Uncertain significance, not provided
- D77Y (p.Asp77Tyr), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- D77V (p.Asp77Val), gnomAD 5-83490257-A-T, REVEL 0.49, CADD 27.70
- D77D (p.Asp77Asp), rs764219060, gnomAD 5-83490258-T-C, CADD 8.53
- K79K (p.Lys79Lys), gnomAD 5-83490264-A-G, CADD 9.89
- K79N (p.Lys79Asn), gnomAD 5-83490264-A-T, REVEL 0.24, CADD 23.90
- E80D (p.Glu80Asp), TOPMed rs919663299
- E80Q (p.Glu80Gln), TOPMed rs1744935690
- T81S (p.Thr81Ser), Ensembl rs910324938, REVEL 0.17, CADD 24.30
- T81P (p.Thr81Pro), gnomAD 5-83490268-A-C, REVEL 0.39, CADD 25.40
- T81T (p.Thr81Thr), rs1484053798, gnomAD 5-83490270-T-C, CADD 1.19
Public VCAN analysis runs
- VCAN analysis run — VCAN (4,677 variants) — completed 2026-08-22